About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-COX1
A6307G
A6474G
A7222G
A7222G-F1
A7299G
A7445C
A7445G
A7445G-F6
A7445G-F5
A7445G-F4
A7445G-F7
A7445T
C6328T
C6489A
C6489A-F1
C6597A
C6597A-F1
G5906A
G5913A-F1
G5913A
G5920A
G6261A
G6480A
G6480A-F1
G6579A
G6708A
G6955A
G6962A
G7023A
G7444A
G7444A-F21
G7444A-F9
T6459C
T6459C-F1
T6526C
T6547C
T6721C
T6742C
G6930A
Edit by Mitofam Team
-
+
首页
A7445G
# General Information | **Position** | **7445** | **Variant** | **m.7445A\>G** | **Locus** | **MT\-CO1** | **Amino\-AcidChange** | **Term514Term** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \+ | **Heteroplasmy** | \+ | **APOGEE2** | NA | **Pathogenicity** | Cfrm \[P] | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # Pedigree Information The **m.7445A\>G** variant in MT\-CO1 has been reported in 9 pedigrees. To date, 16 carriers have been reported. Homoplasmy was reported in 12/16 carriers (75%), and 14/16 carriers (87\.5%) were affected. The main clinical manifestations among affected carriers included progressive bilateral sensorineural hearing loss, sensorineural hearing loss, palmoplantar keratoderma, 110 dB, 58 dB, long\-standing bilateral sensorineural hearing loss, moderate progressive hearing loss, moderate sensorineural hearing loss, and other features. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 7445 | m.7445A\>G | A7445G\-F1 | Polish | Nonsyndromic or aminoglycoside\-induced hearing loss | 1 | 5 | 2011 | [21621438](https://pubmed.ncbi.nlm.nih.gov/21621438/) | G39 | | 2 | 7445 | m.7445A\>G | A7445G\-F2 | Chinese | Hearing loss | ND | ND | 2020 | [32169613](https://pubmed.ncbi.nlm.nih.gov/32169613/) | SD321 | | 3 | 7445 | m.7445A\>G | A7445G\-F9 | UK | Nonsyndromic sensorineural hearing loss | 28 | 10 | 1994 | [7994888](https://pubmed.ncbi.nlm.nih.gov/7994888/) | | | 4 | 7445 | m.7445A\>G | A7445G\-F8 | New Zealand | Palmoplantar keratoderma and sensorineural hearing loss | ND | ND | 1995 | [8572257](https://pubmed.ncbi.nlm.nih.gov/8572257/) | | | 5 | 7445 | m.7445A\>G | A7445G\-F3 | Japan | Palmoplantar keratoderma and sensorineural hearing loss | NA | NA | 1998 | [9450881](https://pubmed.ncbi.nlm.nih.gov/9450881/) | Japanese pedigree | | 6 | 7445 | m.7445A\>G | [A7445G\-F4](https://mitofam.com/doc/889/) | France | Palmoplantar keratoderma and sensorineural hearing loss | 5 | 3 | 2000 | [11069477](https://pubmed.ncbi.nlm.nih.gov/11069477/) | | | 7 | 7445 | m.7445A\>G |[ A7445G\-F5](https://mitofam.com/doc/890/) | Ukraine | Nonsyndromic sensorineural hearing loss | 4 | 6 | 2001 | [11175301](https://pubmed.ncbi.nlm.nih.gov/11175301/) | | | 8 | 7445 | m.7445A\>G | [A7445G\-F6](https://mitofam.com/doc/891/) | Hungary | Nonsyndromic sensorineural hearing loss | 3 | 2 | 2008 | [18537605](https://pubmed.ncbi.nlm.nih.gov/18537605/) | | | 9 | 7445 | m.7445A\>G | [A7445G\-F7](https://mitofam.com/doc/892/) | Japan | Progressive sensorineural hearing loss | 0 | 6 | 2018 | [29605341](https://pubmed.ncbi.nlm.nih.gov/29605341/) | | # Carrier Information | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 7445 | m.7445A\>G | A7445G\-F1 | A7445G\-F1\-III\-1 | Fam | M | Y | Y | A | 2y onset | Homo | / | / | / | Moderate progressive hearing loss; PTA 68/58 dB | Aminoglycoside exposure\=Yes; ; homoplasmic sequence variant | | 2 | 7445 | m.7445A\>G | A7445G\-F2 | A7445G\-F2\-P1 | Uninf | F | Y | Y | A | \<1y onset | Homo | / | / | / | Profound hearing loss; PTA 100/110 dB | Aminoglycoside exposure\=Yes | | 3 | 7445 | m.7445A\>G | A7445G\-F9 | A7445G\-F9\-III\-29 | Fam | ND | Y | Y | A | ND | Homo | / | / | / | Progressive bilateral sensorineural hearing loss | | | 4 | 7445 | m.7445A\>G | A7445G\-F8 | A7445G\-F8\-IV\-5 | Fam | ND | Y | Y | A | ND | \>95% | / | / | / | Progressive sensorineural hearing loss, palmoplantar keratoderma | | | 5 | 7445 | m.7445A\>G | A7445G\-F3 | A7445G\-F3\-P1 | Fam | ND | Y | Y | A | ND | Homo | / | / | / | Sensorineural hearing loss, palmoplantar keratoderma | Japanese pedigree | | 6 | 7445 | m.7445A\>G | A7445G\-F4 | A7445G\-F4\-III1 | Fam | F | Y | Y | A | 15 | Homo | / | / | / | Plantar keratoderma, bilateral sensorineural deafness | | | 7 | 7445 | m.7445A\>G | A7445G\-F4 | A7445G\-F4\-III2 | Fam | M | N | Y | A | 11 | Homo | / | / | / | Moderate sensorineural hearing loss | | | 8 | 7445 | m.7445A\>G | A7445G\-F5 | A7445G\-F5\-IV1 | Fam | F | Y | Y | A | 20 | Homo | / | / | / | Progressive bilateral sensorineural hearing loss | | | 9 | 7445 | m.7445A\>G | A7445G\-F5 | A7445G\-F5\-IV2 | Fam | F | N | Y | A | 15 | Homo | / | / | / | Progressive bilateral sensorineural hearing loss | | | 10 | 7445 | m.7445A\>G | A7445G\-F5 | A7445G\-F5\-III2 | Fam | F | N | Y | A | 28 | Homo | / | / | / | Long\-standing bilateral sensorineural hearing loss | | | 11 | 7445 | m.7445A\>G | A7445G\-F5 | A7445G\-F5\-III3 | Fam | M | N | Y | A | ND | Homo | / | / | / | Nonsyndromic hearing impairment | | | 12 | 7445 | m.7445A\>G | A7445G\-F6 | A7445G\-F6\-III2 | Fam | ND | Y | Y | A | ND | Homo | / | / | / | Sensorineural hearing loss | | | 13 | 7445 | m.7445A\>G | A7445G\-F6 | A7445G\-F6\-II2 | Fam | F | N | N | A | ND | Homo | / | / | / | Normal hearing | | | 14 | 7445 | m.7445A\>G | A7445G\-F6 | A7445G\-F6\-I2 | Uninf | F | N | ND | A | ND | 90% | / | / | / | Healthy | | | 15 | 7445 | m.7445A\>G | A7445G\-F7 | A7445G\-F7\-IV2 | Fam | M | Y | Y | A | 1 | 87\.3% | / | / | 86\.3%(F) | Progressive sensorineural hearing loss in infancy | | | 16 | 7445 | m.7445A\>G | A7445G\-F7 | A7445G\-F7\-III4 | Fam | F | N | Y | A | ND | 86% | / | / | / | Progressive sensorineural hearing loss since childhood | Mother of proband | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月26日 16:56
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)